Drug combination studies and their synergy quantification using the Chou-Talalay method
- PMID: 20068163
- DOI: 10.1158/0008-5472.CAN-09-1947
Drug combination studies and their synergy quantification using the Chou-Talalay method
Abstract
This brief perspective article focuses on the most common errors and pitfalls, as well as the do's and don'ts in drug combination studies, in terms of experimental design, data acquisition, data interpretation, and computerized simulation. The Chou-Talalay method for drug combination is based on the median-effect equation, derived from the mass-action law principle, which is the unified theory that provides the common link between single entity and multiple entities, and first order and higher order dynamics. This general equation encompasses the Michaelis-Menten, Hill, Henderson-Hasselbalch, and Scatchard equations in biochemistry and biophysics. The resulting combination index (CI) theorem of Chou-Talalay offers quantitative definition for additive effect (CI = 1), synergism (CI < 1), and antagonism (CI > 1) in drug combinations. This theory also provides algorithms for automated computer simulation for synergism and/or antagonism at any effect and dose level, as shown in the CI plot and isobologram, respectively.
Comment in
-
Drug combination studies and their synergy quantification using the Chou-Talalay method--letter.Cancer Res. 2015 Jun 1;75(11):2400. doi: 10.1158/0008-5472.CAN-14-3763. Cancer Res. 2015. PMID: 25977339 No abstract available.
Similar articles
-
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies.Pharmacol Rev. 2006 Sep;58(3):621-81. doi: 10.1124/pr.58.3.10. Pharmacol Rev. 2006. PMID: 16968952 Review.
-
Drug combination studies and their synergy quantification using the Chou-Talalay method--letter.Cancer Res. 2015 Jun 1;75(11):2400. doi: 10.1158/0008-5472.CAN-14-3763. Cancer Res. 2015. PMID: 25977339 No abstract available.
-
Synergistic combination of microtubule targeting anticancer fludelone with cytoprotective panaxytriol derived from panax ginseng against MX-1 cells in vitro: experimental design and data analysis using the combination index method.Am J Cancer Res. 2015 Dec 15;6(1):97-104. eCollection 2016. Am J Cancer Res. 2015. PMID: 27073727 Free PMC article.
-
The mass-action law based algorithms for quantitative econo-green bio-research.Integr Biol (Camb). 2011 May;3(5):548-59. doi: 10.1039/c0ib00130a. Epub 2011 Mar 14. Integr Biol (Camb). 2011. PMID: 21403972
-
Preclinical versus clinical drug combination studies.Leuk Lymphoma. 2008 Nov;49(11):2059-80. doi: 10.1080/10428190802353591. Leuk Lymphoma. 2008. PMID: 19021049 Review.
Cited by
-
Sensitization of melanoma cells to standard chemotherapy: G-quadruplex binders as synergistic agents.NAR Cancer. 2024 Oct 30;6(4):zcae042. doi: 10.1093/narcan/zcae042. eCollection 2024 Dec. NAR Cancer. 2024. PMID: 39478935 Free PMC article.
-
Dual Inhibition of Ornithine Decarboxylase and A1 Adenosine Receptor Efficiently Suppresses Breast Tumor Cells.Front Oncol. 2021 Mar 11;11:636373. doi: 10.3389/fonc.2021.636373. eCollection 2021. Front Oncol. 2021. PMID: 33777791 Free PMC article.
-
Repurposing metformin, simvastatin and digoxin as a combination for targeted therapy for pancreatic ductal adenocarcinoma.Cancer Lett. 2020 Oct 28;491:97-107. doi: 10.1016/j.canlet.2020.08.002. Epub 2020 Aug 21. Cancer Lett. 2020. PMID: 32829010 Free PMC article.
-
MDL-800, an allosteric activator of SIRT6, suppresses proliferation and enhances EGFR-TKIs therapy in non-small cell lung cancer.Acta Pharmacol Sin. 2021 Jan;42(1):120-131. doi: 10.1038/s41401-020-0442-2. Epub 2020 Jun 15. Acta Pharmacol Sin. 2021. PMID: 32541922 Free PMC article.
-
Anticancer potential of mebendazole against chronic myeloid leukemia: in silico and in vitro studies revealed new insights about the mechanism of action.Front Pharmacol. 2022 Aug 25;13:952250. doi: 10.3389/fphar.2022.952250. eCollection 2022. Front Pharmacol. 2022. PMID: 36091760 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical